Log in to your Inderes Free account to see all free content on this page.
2cureX
1.00 SEK
Less than 1K followers
2CUREX
First North Stockholm
Medical Equipment & Services
Health Care
Overview
Financials & Estimates
Ownership
-8.62 %
-6.92 %
-63.65 %
-77.52 %
+136.02 %
+118.42 %
-88.80 %
-94.11 %
-86.91 %
2cureX is a Danish-based biotech company with subsidiary in Hamburg, Germany. The company has made a special sensitivity test, IndiTreat, for oncology clinics that is focused on improving the outcome for cancer patients by improving the efficiency of the individual cancer treatment. IndiTreat uses a biopsy from the individual cancer patient to measure and predict the likely outcome of different available treatments, thereby assisting oncologists to choose the most effective treatment for the individual patient.
Read moreMarket cap
25M SEK
Turnover
-
Revenue
EBIT %
P/E
Dividend yield-%
Revenue and EBIT-%
Revenue K
EBIT-% (adj.)
EPS and dividend
EPS (adj.)
Dividend %
Financial calendar
26.2.
2026
Annual report '25
All
Press releases
ShowingAll content types
2cureX AB (“2cureX”) hereby publishes the interim report for the first half year of 2025.
Improved communication from 2cureX AB
Join Inderes community
Don't miss out - create an account and get all the possible benefits
FREE account
Stock market's most popular morning newsletter
Analyst comments and recommendations
Stock comparison tool
PREMIUM account
All company reports and content
Premium tools (e.g. insider transactions & stock screener)
Model portfolio